Solaris Endovascular announced 12-month results from the Solaris SX iliac postmarket clinical follow-up study of the company&rs ...
Bentley InnoMed GmbH, which is headquartered in Hechingen, Germany, announced the first-in-human use of the company’s BeG ...
Angiolutions announced that the first patient has been treated in a first-in-human (FIH) study evaluating the safety and ...
Rampart IC, a developer of radiation shielding for interventional suites, announced new data on the reduction in radiation ...
Penumbra Inc. announced it has secured CE Mark approval for its Lightning Bolt 12 and Lightning Bolt 6X with Trax. These next-g ...
Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced it has secured a $53 million firs ...
Royal Philips announced the expanded commercial availability of its LumiGuide device guidance across Europe and the United Stat ...
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results